Literature DB >> 19234505

A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis.

V Gupta, N Kröger, J Aschan, W Xu, B Leber, C Dalley, M Sabloff, J H Lipton, H Messner, M Brune.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19234505     DOI： 10.1038/bmt.2009.10

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  20 in total

1.  Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis.

Authors:  Markus Ditschkowski; Ahmet H Elmaagacli; Rudolf Trenschel; Tanja Gromke; Nina K Steckel; Michael Koldehoff; Dietrich W Beelen
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

2.  Effect of conditioning regimens on graft failure in myelofibrosis: a retrospective analysis.

Authors:  S Slot; K Smits; N W C J van de Donk; B I Witte; R Raymakers; J J W M Janssen; A E C Broers; P A W Te Boekhorst; S Zweegman
Journal:  Bone Marrow Transplant       Date:  2015-08-03       Impact factor: 5.483

3.  Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantation.

Authors:  B K Hamilton; L Rybicki; J Dabney; L McLellan; H Haddad; L Foster; D Abounader; M Kalaycio; R Sobecks; R Dean; H Duong; B T Hill; B J Bolwell; E A Copelan
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

Review 4.  Role of hematopoietic stem cell transplantation in patients with myeloproliferative disease.

Authors:  Rachel B Salit; H Joachim Deeg
Journal:  Hematol Oncol Clin North Am       Date:  2014-10-03       Impact factor: 3.722

5.  Myelofibrosis 2012: it's complicated.

Authors:  Harper G Hubbeling; Dale M Frank; Elizabeth O Hexner
Journal:  Ther Adv Hematol       Date:  2012-06

Review 6.  Indications and outcomes of reduced-toxicity hematopoietic stem cell transplantation in adult patients with hematological malignancies.

Authors:  S Fadilah Abdul Wahid
Journal:  Int J Hematol       Date:  2013-04-13       Impact factor: 2.490

Review 7.  Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors.

Authors:  Vikas Gupta; Parameswaran Hari; Ronald Hoffman
Journal:  Blood       Date:  2012-06-14       Impact factor: 22.113

Review 8.  Current Challenges in Stem Cell Transplantation in Myelofibrosis.

Authors:  Nicolaus Kröger
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

9.  Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosis.

Authors:  David S Snyder; Joycelynne Palmer; Karl Gaal; Anthony S Stein; Vinod Pullarkat; Firoozeh Sahebi; Nyana Vora; Ryotaro Nakamura; Stephen J Forman
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-26       Impact factor: 5.742

10.  Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib.

Authors:  N Jaekel; G Behre; A Behning; C Wickenhauser; T Lange; D Niederwieser; H K Al-Ali
Journal:  Bone Marrow Transplant       Date:  2013-12-02       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.